ABI
MDVN

Adamant Biomedical Investments’s MEDIVATION, INC. MDVN Stock Holding History

Adamant Biomedical Investments’s Portfolio MDVN Stock Details MDVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$6.47M Buy
130,000
+90,000
+225% +$4.68M 1.55% 20
2014
Q3 		$1.98M Buy
+40,000
New +$1.7M 0.49% 57

Other funds holding MDVN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Adamant Biomedical Investments's MDVN Position: Q4 2014 in Review

Adamant Biomedical Investments increased its MEDIVATION, INC. (MDVN) stake by 225% in Q4 2014, buying an estimated $4.68M and bringing the position to 130,000 shares worth $6.47M. The position accounts for 1.55% of the portfolio, ranked #20.

Adamant Biomedical Investments first reported a position in MDVN in Q3 2014 and has held it in 2 quarters since. 337 funds tracked by Wall St. Rank hold MDVN as of Q4 2014.

  • Adamant Biomedical Investments held 130,000 shares of MEDIVATION, INC. worth $6.47M as of Q4 2014.
  • Adamant Biomedical Investments bought 90,000 MEDIVATION, INC. shares in Q4 2014, an estimated $4.68M.
  • MEDIVATION, INC. made up 1.55% of Adamant Biomedical Investments's portfolio in Q4 2014, its #20 holding.
  • Adamant Biomedical Investments first reported a position in MEDIVATION, INC. in Q3 2014 and has held it in 2 quarters since.
  • 337 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.